Nuvectis Pharma Inc (NVCT) — Financial Flexibility Index
Nuvectis Pharma Inc (NVCT) has a Financial Flexibility Index of -0.34x as of June 2026. Free cash flow of $-4.53 Million (operating CF $-4.53 Million minus capex $0.00) represents 0% of total liabilities ($13.29 Million). Check Nuvectis Pharma Inc (NVCT) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nuvectis Pharma Inc Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Nuvectis Pharma Inc across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Nuvectis Pharma Inc.
Annual Financial Flexibility Index for Nuvectis Pharma Inc (2020–2025)
Year-by-year free cash flow to debt coverage for Nuvectis Pharma Inc. Explore Nuvectis Pharma Inc (NVCT) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.20x | $-16.01 Million | $-16.01 Million | $13.30 Million | ▲ +12.6% |
| 2024 | -1.38x | $-12.25 Million | $-12.25 Million | $8.89 Million | ▲ +39.7% |
| 2023 | -2.28x | $-15.95 Million | $-15.95 Million | $6.98 Million | ▼ -4.2% |
| 2022 | -2.19x | $-13.56 Million | $-13.56 Million | $6.19 Million | ▼ -307.4% |
| 2021 | -0.54x | $-9.50 Million | $-9.50 Million | $17.66 Million | ▼ -122.4% |
| 2020 | 2.40x | $24.00K | $24.00K | $10.00K | — |